U.S. markets closed
  • S&P 500

    3,957.63
    -6.31 (-0.16%)
     
  • Dow 30

    33,852.53
    +3.07 (+0.01%)
     
  • Nasdaq

    10,983.78
    -65.72 (-0.59%)
     
  • Russell 2000

    1,836.55
    +5.59 (+0.31%)
     
  • Crude Oil

    78.71
    +0.51 (+0.65%)
     
  • Gold

    1,762.30
    -1.40 (-0.08%)
     
  • Silver

    21.38
    -0.06 (-0.26%)
     
  • EUR/USD

    1.0324
    -0.0020 (-0.20%)
     
  • 10-Yr Bond

    3.7480
    +0.0450 (+1.22%)
     
  • GBP/USD

    1.1947
    -0.0018 (-0.15%)
     
  • USD/JPY

    138.7500
    -0.1510 (-0.11%)
     
  • BTC-USD

    16,461.52
    +254.24 (+1.57%)
     
  • CMC Crypto 200

    389.69
    +0.96 (+0.25%)
     
  • FTSE 100

    7,512.00
    +37.98 (+0.51%)
     
  • Nikkei 225

    28,027.84
    0.00 (0.00%)
     

Cantor trims Aurora Cannabis price target, reiterates overweight rating

Cantor trims Aurora Cannabis price target, reiterates overweight rating

Cantor Fitzgerald analyst Pablo Zuanic on Wednesday reiterated an overweight rating on Canada's Aurora Cannabis Inc. and reduced his price target to $3 a share from $3.12 a share. Zuanic said he expects no significant changes in top line trends in the coming quarter, after Aurora reported flat sequential fourth-quarter sales of about C$50 million. The company's medical cannabis business with a 24% share in Canada as well as its presence in key markets overseas such as Germany now accounts for mo